Table V.
Adverse Events
| Adverse event (CTCAEv3) |
Gr 3 #(%) |
Gr 4 #(%) |
|---|---|---|
| Skin | 5 (10%) | 0 |
| Hepatic transaminases | 5 (10%) | 3 (6%) |
| Pulmonary | 18 (36%) | 5 (10%) |
| Infection | 12 (24%) | 8 (16%) |
| Gastrointestinal | 6 (12%) | 0 |
| Hyperbilirubinaemia | 3 (6%) | 1 (2%) |
| Renal | 2 (4%) | 0 |
| Pain | 1 (2%) | 0 |
| Neuropathy | 1 (2%) | 0 |
| Tumour lysis | 1 (2%) | 0 |
CTCAEv3, Common Terminology Criteria for Adverse Events v3.0